Are national policies and programs for prevention and management of postpartum hemorrhage and preeclampsia adequate? A key informant survey in 37 countries

JM Smith, S Currie, T Cannon… - Global Health: Science …, 2014 - ghspjournal.org
Introduction: Although maternal mortality has declined substantially in recent years, efforts to
address postpartum hemorrhage (PPH) and preeclampsia/eclampsia (PE/E) must be …

[HTML][HTML] Postpartum hemorrhage prevention in Nepal: a program assessment

SP Rajbhandari, K Aryal, WR Sheldon, B Ban… - BMC Pregnancy and …, 2017 - Springer
Abstract Background In 2009, the Nepal Ministry of Health and Population launched a
national program for prevention of postpartum hemorrhage (PPH) during home births that …

Prevention of postpartum hemorrhage in low-resource settings: current perspectives

N Prata, S Bell, K Weidert - International journal of women's health, 2013 - Taylor & Francis
Background Postpartum hemorrhage (PPH) is the leading cause of maternal death in low-
income countries and is the primary cause of approximately one-quarter of global maternal …

New global guidance supports community and lay health workers in postpartum hemorrhage prevention

CL Ejembi, P Norick, A Starrs, K Thapa - International Journal of …, 2013 - Elsevier
New global guidance has emerged to support countries as they consider introducing or
scaling-up misoprostol for postpartum hemorrhage (PPH). The World Health Organization …

[HTML][HTML] Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date

JM Smith, R Gubin, MM Holston, J Fullerton… - BMC pregnancy and …, 2013 - Springer
Background Hemorrhage continues to be a leading cause of maternal death in developing
countries. The 2012 World Health Organization guidelines for the prevention and …

[HTML][HTML] Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings

DL Lang, FL Zhao, J Robertson - BMC Pregnancy and Childbirth, 2015 - Springer
Background While inferior to oxytocin injection in both efficacy and safety, orally
administered misoprostol has been included in the World Health Organization Model List of …

[BOOK][B] WHO recommendations for the prevention and treatment of postpartum haemorrhage

World Health Organization - 2012 - apps.who.int
Postpartum Haemorrhage (PPH) is commonly defined as a blood loss of 500 ml or more
within 24 hours after birth. PPH is the leading cause of maternal mortality in low-income …

Postpartum hemorrhage in developing countries: is the public health community using the right tools?

VD Tsu, A Langer, T Aldrich - International journal of …, 2004 - Wiley Online Library
Objectives: To identify new and underutilized technologies that may assist in reducing
maternal mortality due to obstetric hemorrhage. Methods: Review of published and …

Should oral misoprostol be used to prevent postpartum haemorrhage in home‐birth settings in low‐resource countries? A systematic review of the evidence

VA Hundley, BI Avan, CJ Sullivan… - BJOG: An International …, 2013 - Wiley Online Library
Background Using misoprostol to prevent postpartum haemorrhage (PPH) in home‐birth
settings remains controversial. Objectives To review the safety and effectiveness of oral …

Interpretation of national policy regarding community‐based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: A tale of two regions

SA Spangler, AG Gobezayehu… - Journal of midwifery …, 2014 - Wiley Online Library
Introduction Postpartum hemorrhage (PPH) is responsible for a significant proportion of
maternal mortality in developing countries. The uterotonic drug misoprostol (Cytotec) is a …